SST and hepatocellular carcinoma: The specific SST1 agonist L-797,591 was the only SST agonist to inhibit both liver cancer cell and hepatic stellate cell migration, making SST1 agonists putatively interesting to treat liver cirrhosis or HCC (Reynaert et al., 2004).